| 产品详情 |
| Edit |   |
| Product Name | AG-1296 |
| Description | Purity >98%. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. Tyrphostins are a class of antiproliferative compounds which act as PTK blockers. PTK inhibitors specific for platelet-derived growth factor (PDGF) receptor kinase could help in the treatment of atherosclerosis, restenosis, pulmonary fibrosis, and gliomas. AG-1296 is a potent and selective inhibitor of PDGF receptor kinase with an IC50 value of about 0.4 µM both in vitro and in cells (Swiss 3T3 cells). It inhibits ligand-stimulated DNA synthesis in platelet-derived growth factor receptor and stem cell factor/kit receptor transfected cells with an IC50 values of 1.5 and 1.8 µM, respectively. 2 Treatment of sis oncogene transfected NIH3T3 cells with AG-1296 reverses the transformed phenotype. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | 6,7-dimethoxy-2-phenyl-quinoxaline, Tyrphostin AG-1296 |
| Gene, Accession, CAS # | CAS: 146535-11-7 |
| Catalog # | LS-H6432 |
| Price | |
| Order / More Info | AG-1296 from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|